UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Q: What does CUSIP M96088105 represent in this 13F holders report?

CUSIP M96088105 is the security identifier for URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in Q1 2021?

88 institutional investors reported URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: M96088105

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding: 46,986,408
Total 13F shares: 14,299,652
Share change: -219,433
Total reported value: $278,497,797
Put/Call ratio: 0%
Price per share: $19.48
Number of holders: 88
Value change: -$4,203,728
Number of buys: 31
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP M96088105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MENORA MIVTACHIM HOLDINGS LTD.	13F	Company	6.3%	2,954,699	$53,244,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.9%	1,840,637	$33,169,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	3.3%	1,529,491	$27,561,000	—	31 Dec 2020	13F
Wildcat Capital Management, LLC	13F	Company	2.7%	1,252,285	$22,566,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	2.4%	1,121,071	$20,202,000	—	31 Dec 2020	13F
Phoenix Financial Ltd.	13F	Company	1.7%	819,682	$14,750,000	—	31 Dec 2020	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	1.6%	738,302	$13,304,000	—	31 Dec 2020	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	1.1%	529,388	$8,913,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.94%	440,411	$7,936,000	—	31 Dec 2020	13F
Horton Capital Management, LLC	13F	Company	0.83%	390,428	$7,036,000	—	31 Dec 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.74%	347,867	$6,268,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.51%	239,380	$4,314,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.42%	197,690	$3,562,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.37%	175,292	$3,159,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.31%	146,642	$2,642,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.28%	129,741	$2,338,000	—	31 Dec 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.22%	102,053	$1,839,000	—	31 Dec 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.21%	96,904	$1,746,000	—	31 Dec 2020	13F
Annandale Capital, LLC	13F	Company	0.18%	86,254	$1,554,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.18%	84,982	$1,532,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	0.18%	83,229	$1,500,000	—	31 Dec 2020	13F
ARK Investment Management LLC	13F	Company	0.16%	73,769	$1,329,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.15%	71,522	$1,289,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.12%	57,221	$1,030,000	—	31 Dec 2020	13F
SG Americas Securities, LLC	13F	Company	0.12%	56,244	$1,014,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.11%	51,881	$935,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	48,930	$882,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.1%	47,603	$858,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.09%	42,500	$766,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	41,036	$740,000	—	31 Dec 2020	13F
SHIKIAR ASSET MANAGEMENT INC	13F	Company	0.09%	39,950	$720,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	39,400	$710,000	—	31 Dec 2020	13F
Coastal Bridge Advisors, LLC	13F	Company	0.08%	37,000	$667,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	36,326	$655,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	34,186	$616,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.07%	34,021	$613,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.07%	32,800	$591,000	—	31 Dec 2020	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.07%	32,603	$590,000	—	31 Dec 2020	13F
Aperio Group, LLC	13F	Company	0.07%	31,421	$566,000	—	31 Dec 2020	13F
BANK HAPOALIM BM	13F	Company	0.06%	30,020	$541,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	29,569	$533,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.06%	28,819	$519,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	28,648	$516,000	—	31 Dec 2020	13F
Palo Alto Investors LP	13F	Company	0.05%	24,500	$441,000	—	31 Dec 2020	13F
Altshuler Shaham Ltd	13F	Company	0.05%	23,501	$423,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.05%	22,400	$403,648	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	21,900	$395,000	—	31 Dec 2020	13F
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD	13F	Company	0.05%	21,823	$393,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	19,900	$359,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.04%	17,178	$310,000	—	31 Dec 2020	13F

Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q1 2021

As of 31 Mar 2021, UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,299,652 shares. The largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, CREDIT SUISSE AG/, Migdal Insurance & Financial Holdings Ltd., Horton Capital Management, LLC, Phoenix Holdings Ltd., Wildcat Capital Management, LLC, Clal Insurance Enterprises Holdings Ltd, and ZEKE CAPITAL ADVISORS, LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.